Zoekresultaten - 273 results

Trends in Hospital Antibacterial Consumption in Belgium (2017-2021): Evaluating the Impact of the COVID-19 Pandemic

Daily Doses (DDD s), and AMC was expressed in DDD s/1000 inhabitants/day (DID s), DDD s/1000 patient days and DDD s/1000 admissions. Linear regressions were employed to analyze 5-year trends for the ATC ...

Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.

strain) of clade 2.3.4.4c was evaluated in specific pathogen-free (SPF) white leghorn chickens against a homologous and heterologous H5 HPAI viruses. A single vaccination at 2 weeks of age (1 dose), and ...

Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.

associated with the uptake of COVID-19 vaccine in Belgium. METHODS: We conducted a cross-sectional analysis of the uptake of a first COVID-19 vaccine dose among 5 342 110 adults (≥18 years) in Belgium on 31 ...

A Benchmark Dose-based strategy for evaluating the combined effects of genotoxic compounds

Belgium (2023) Keywords: benchmark dose modelling genotoxicity mixtures Health Topics:  Food consumption and food safety Consommation et sécurité alimentaires Voedselconsumptie en –veiligheid Service:  ...

Towards Characterization and genotoxicity assessment of mycotoxin mixtures present in food.

Mertens Source: BelTox Annual Meeting, Brussels, Belgium (2023) Keywords: additivity benchmark dose modelling genotoxicity mixtures Mycotoxins Health Topics:  Food consumption and food safety Consommation ...

Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries

This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses, against hospitalisation due to COVID-19 and COVID-19 related deaths in resident ...

Factors underlying COVID-19 booster vaccine uptake among adults in Belgium

likely to receive the subsequent booster dose compared to COVID-naïve individuals. This information could be used to guide future vaccination campaigns during a pandemic and can provide valuable insights ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.

series vaccination (PSV) and first booster dose vaccination as last dose of either vaccine received ≥ 14 days before symptom onset (stratifying first booster into received < 150 and ≥ 150 days after ...

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.

2021.MethodsForty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. We defined complete primary series vaccination (PSV) as two doses of ...

Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)

COVID-19 was rolled out to the adult population in Belgium, followed by the first booster campaign towards the end of the year. At the beginning of 2022, booster doses were recommended and offered to people ...

QR code

QR code for this page URL